Skip to main content
Clinical Trials/NCT00442247
NCT00442247UnknownNot Applicable

A Randomised, Controlled Study of Bimesh, Pelvicol for Vaginal Wall Prolapse

Zealand University Hospital1 site in 1 country60 target enrollmentStarted: September 1, 2004Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
60
Locations
1
Primary Endpoint
Difference in POP-Q measurements for vaginal prolapse

Study Overview

Brief Summary

Anterior vaginal wall prolapse is a common problem. Until now many different surgical techniques have been evaluated but so far recurrence is often still observed. Therefore, synthetic mesh or biomesh for vaginal prolapse reconstruction have been introduced.

Detailed Description

Anterior vaginal wall prolapse is a common problem. Until now many different surgical techniques have been evaluated but so far recurrence is often still observed. Therefore, synthetic mesh or biomesh for vaginal prolapse reconstruction have been introduced. However, is is now known whether these methods are superior to the replication of the pubocervicale fascia, a method which is well described and have been used for many years. Furthermore, most studies evaluating the used of mesh for anterior vaginal wall prolapse have not been controlled studies and been irrespective to whether the repair was a primary or secondary operation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
55 Years to 75 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Anterior vaginal wall prolapse greater than grade 2 ICS qualifications, International Continence Society Committee for Standardisation of Terminology

Exclusion Criteria

  • •Recurrent vaginal prolapse, wault prolapse

Outcomes

Primary Outcomes

Difference in POP-Q measurements for vaginal prolapse

Secondary Outcomes

  • Affect on bladder function after surgery for anterior vaginal wall prolapse

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials